Business Name: |
Glentech Inc |
Contact Person: |
Roberto Campos |
Address: |
10975 Torreyana Road, San Diego, California 92121 |
Phone Number: |
(858) 812-8800 |
Website Address: |
bd.com |
Annual Revenue (USD): |
$10.000.000 to $19.9999.999 |
Founding Year: |
1998 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Medical Labs |
SIC Code: |
8071 |
NAICS Code: |
621511 |
Share This Business: |
|
Related Businesses: |
Lab Corp - San Diego, CA 92121 Erik & Ese Banck Clinical - San Diego, CA 92121 Applied Proteomics Inc - San Diego, CA 92121 Jm Bioscience - San Diego, CA 92121 Edan Diagnostics Inc - San Diego, CA 92121 Mvk Inc - San Diego, CA 92121 Us Specialty Labs - San Diego, CA 92121 Ucsd Center For Molecular Imaging - San Diego, CA 92121 Life Chem Laboratories - San Diego, CA 92121 Medistem Inc - San Diego, CA 92121 Check for STDs San Diego - San Diego, CA 92121 Emerald Digital Diagnostics - San Diego, CA 92121 Orphagen Pharmacy - San Diego, CA 92121 Bio Theranostics Inc - San Diego, CA 92121 Attenuon LLC - San Diego, CA 92121 Prescos LLC - San Diego, CA 92121 Esoterix Oncology Inc - San Diego, CA 92121 Laboratory Corporation Of America - San Diego, CA 92121 Biotheranostics - San Diego, CA 92121 Roche Laboratories Inc - San Diego, CA 92121 |
The company Glentech Inc provides B2C services in the form of Medical Labs from its single location in California.
1 to 4 employees work for Glentech Inc, and the business now earns $10.000.000 to $19.9999.999 per annum.
Glentech Inc was launched in 1998 and is classified under SIC code and category 8071 , and NAICS number and grouping 621511 .
To contact Glentech Inc, please call Roberto Campos with the phone number (858) 812-8800 or visit its single location at 10975 Torreyana Road in San Diego, California 92121.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage bd.com or follow the company’s social media accounts, on Twitter and on Facebook.